Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease

NCT04238299 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 486

Last updated 2026-05-12

No results posted yet for this study

Summary

Research question: Can multiparametric renal Magnetic Resonance Imaging (MRI) provide structural and functional assessment of the kidneys to deliver prognostic information and guide treatment options in chronic kidney disease (CKD)?

Aims and objectives:

1. To establish a multiparametric renal MRI protocol in CKD cohorts.
2. To use multiparametric MRI to characterise people with and without CKD progression.
3. To compare multiparametric renal MRI with 'gold-standard' renal biopsy to determine pathological processes of CKD progression that are detectable by MRI.

Conditions

  • Chronic Kidney Diseases

Interventions

DIAGNOSTIC_TEST

Multiparametric renal MRI

Localiser scans; Kidney volume; Longitudinal (T1) relaxation time mapping; Diffusion weighted imaging (DWI); Phase Contrast MRI; Arterial spin labelling (ASL); Blood Oxygen Level Dependent (BOLD) mapping

Sponsors & Collaborators

  • University of Nottingham

    collaborator OTHER
  • Queen Elizabeth University Hospital Glasgow

    collaborator UNKNOWN
  • Royal Infirmary of Edinburgh

    collaborator OTHER
  • University of Edinburgh

    collaborator OTHER
  • Newcastle University

    collaborator OTHER
  • Newcastle-upon-Tyne Hospitals NHS Trust

    collaborator OTHER
  • University of Leeds

    collaborator OTHER
  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER
  • Sheffield Teaching Hospitals NHS Foundation Trust

    collaborator OTHER
  • University of Sheffield

    collaborator OTHER
  • Northern Care Alliance NHS Foundation Trust

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • University of Cambridge

    collaborator OTHER
  • Cambridge University Hospitals NHS Foundation Trust

    collaborator OTHER
  • University Hospitals of Derby and Burton NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2027-02-28
Completion
2033-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04238299 on ClinicalTrials.gov